RT Journal Article
SR Electronic
T1 Prolonged activation of nasal immune cell populations and development of tissue-resident SARS-CoV-2 specific CD8 T cell responses following COVID-19
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.04.19.21255727
DO 10.1101/2021.04.19.21255727
A1 Roukens, Anna H.E.
A1 König, Marion
A1 Dalebout, Tim
A1 Tak, Tamar
A1 Azimi, Shohreh
A1 Kruize, Yvonne
A1 Pothast, Cilia R.
A1 Hagedoorn, Renate S.
A1 Arbous, Sesmu M.
A1 Zhang, Jaimie L. H.
A1 Verheij, Maaike
A1 Prins, Corine
A1 van der Does, Anne M.
A1 Hiemstra, Pieter S.
A1 de Vries, Jutte J.C.
A1 Janse, Jacqueline J.
A1 Roestenberg, Meta
A1 Myeni, Sebenzile K.
A1 Kikkert, Marjolein
A1 Heemskerk, Mirjam H.M.
A1 Yazdanbakhsh, Maria
A1 Smits, Hermelijn H.
A1 Jochems, Simon P.
A1 ,
YR 2021
UL http://medrxiv.org/content/early/2021/04/22/2021.04.19.21255727.abstract
AB The immune system plays a major role in Coronavirus Disease 2019 (COVID-19) pathogenesis, viral clearance and protection against re-infection. Immune cell dynamics during COVID-19 have been extensively documented in peripheral blood, but remain elusive in the respiratory tract. We performed minimally-invasive nasal curettage and mass cytometry to characterize nasal immune cells of COVID-19 patients during and 5-6 weeks after hospitalization. Contrary to observations in blood, no general T cell depletion at the nasal mucosa could be detected. Instead, we observed increased numbers of nasal granulocytes, monocytes, CD11c+ NK cells and exhausted CD4+ T effector memory cells during acute COVID-19 compared to age-matched healthy controls. These pro-inflammatory responses were found associated with viral load, while neutrophils also negatively correlated with oxygen saturation levels. Cell numbers mostly normalized following convalescence, except for persisting CD127+ granulocytes and activated T cells, including CD38+ CD8+ tissue-resident memory T cells. Moreover, we identified SARS-CoV-2 specific CD8+ T cells in the nasal mucosa in convalescent patients. Thus, COVID-19 has both transient and long-term effects on the immune system in the upper airway.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by a MKMD-COVID-19 grant (no. 114025007) from ZonMW and Proefdiervrij. This work was also supported by Wake Up To Corona crowdfunding by Leids Universitair Fonds. SPJ is supported by a LUMC Gisela Thier Fellowship.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethical approval was obtained from the Medical Ethical Committee Leiden-Den Haag-Delft (NL73740.058.20).All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesRaw data is available upon reasonable request from corresponding author under compliance with ethical and regulatory approvals.